Journal article
Phenotypic Variability of Childhood Charcot-Marie-Tooth Disease
JAMA neurology, Vol.73(6), pp.645-651
06/01/2016
DOI: 10.1001/jamaneurol.2016.0171
PMCID: PMC4916861
PMID: 27043305
Abstract
Disease severity of childhood Charcot-Marie-Tooth disease (CMT) has not been extensively characterized, either within or between types of CMT to date.
To assess the variability of disease severity in a large cohort of children and adolescents with CMT.
A cross-sectional study was conducted among 520 children and adolescents aged 3 to 20 years at 8 universities and hospitals involved in the Inherited Neuropathies Consortium between August 6, 2009, and July 31, 2014, in Australia, Italy, the United Kingdom, and the United States. Data analysis was conducted from August 1, 2014, to December 1, 2015.
Scores on the Charcot-Marie-Tooth Disease Pediatric Scale (CMTPedS), a well-validated unidimensional clinical outcome measure to assess disease severity. This instrument includes 11 items assessing fine and gross motor function, sensation, and balance to produce a total score ranging from 0 (unaffected) to 44 (severely affected).
Among the 520 participants (274 males) aged 3 to 20 years, CMT type 1A (CMT1A) was the most prevalent type (252 [48.5%]), followed by CMT2A (31 [6.0%]), CMT1B (15 [2.9%]), CMT4C (13 [2.5%]), and CMTX1 (10 [1.9%]). Disease severity ranged from 1 to 44 points on the CMTPedS (mean [SD], 21.5 [8.9]), with ankle dorsiflexion strength and functional hand dexterity test being most affected. Participants with CMT1B (mean [SD] CMTPedS score, 24.0 [7.4]), CMT2A (29.7 [7.1]), and CMT4C (29.8 [8.6]) were more severely affected than those with CMT1A (18.9 [7.7]) and CMTX1 (males: 15.3 [7.7]; females: 13.0 [3.6]) (P < .05). Scores on the CMTPedS tended to worsen principally during childhood (ages, 3-10 years) for participants with CMT4C and CMTX1 and predominantly during adolescence for those with CMT1B and CMT2A (ages, 11-20 years), while CMT1A worsened consistently throughout childhood and adolescence. For individual items, participants with CMT4C recorded more affected functional dexterity test scores than did those with all other types of CMT (P < .05). Participants with CMT1A and CMTX1 performed significantly better on the 9-hole peg test and balance test than did those with all other types of CMT (P < .05). Participants with CMT2A had the weakest grip strength (P < .05), while those with CMT2A and CMT4C exhibited the weakest ankle plantarflexion and dorsiflexion strength, as well as the lowest long jump and 6-minute walk test distances (P < .05). Multiple regression modeling identified increasing age (r = 0.356, β = 0.617, P < .001) height (r = 0.251, β = 0.309, P = .002), self-reported foot pain (r = 0.162, β = .114, P = .009), and self-reported hand weakness (r = 0.243, β = 0.203, P < .001) as independent predictors of disease severity.
These results highlight the phenotypic variability within CMT genotypes and mutation-specific manifestations between types. This study has identified distinct functional limitations and self-reported impairments to target in future therapeutic trials.
Details
- Title: Subtitle
- Phenotypic Variability of Childhood Charcot-Marie-Tooth Disease
- Creators
- Kayla M D Cornett - University of Sydney & Children's Hospital at Westmead, Sydney AustraliaManoj P Menezes - University of Sydney & Children's Hospital at Westmead, Sydney AustraliaPaula Bray - University of Sydney & Children's Hospital at Westmead, Sydney AustraliaMark Halaki - University of Sydney & Children's Hospital at Westmead, Sydney AustraliaRosemary R Shy - Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa CitySabrina W Yum - Division of Neurology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania4Department of Neurology, Perelman School of Medicine, University of Pennsylvania, PhiladelphiaTimothy Estilow - Neuromucsular Program, The Children's Hospital of Philadelphia, Philadelphia, PennsylvaniaIsabella Moroni - Istituto di Ricovero e Cura a Carattere Scientifico Foundation, Carlo Besta Neurological Institute, Milan, ItalyMaria Foscan - Istituto di Ricovero e Cura a Carattere Scientifico Foundation, Carlo Besta Neurological Institute, Milan, ItalyEmanuela Pagliano - Istituto di Ricovero e Cura a Carattere Scientifico Foundation, Carlo Besta Neurological Institute, Milan, ItalyDavide Pareyson - Istituto di Ricovero e Cura a Carattere Scientifico Foundation, Carlo Besta Neurological Institute, Milan, ItalyMatilde Laurá - Medical Research Council Centre for Neuromuscular Diseases, University College London Institute of Neurology, Queen Square, London, EnglandTrupti Bhandari - University College London Institute of Child Health & Great Ormond Street Hospital, London, EnglandFrancesco Muntoni - University College London Institute of Child Health & Great Ormond Street Hospital, London, EnglandMary M Reilly - Medical Research Council Centre for Neuromuscular Diseases, University College London Institute of Neurology, Queen Square, London, EnglandRichard S Finkel - Neuromuscular Program, Division of Neurology, Nemours Children's Hospital, Orlando, FloridaJanet Sowden - Department of Neurology, University of Rochester, Rochester, New YorkKaty J Eichinger - Department of Neurology, University of Rochester, Rochester, New YorkDavid N Herrmann - Department of Neurology, University of Rochester, Rochester, New YorkMichael E Shy - Department of Neurology, Carver College of Medicine, University of Iowa, Iowa CityJoshua Burns - University of Sydney & Children's Hospital at Westmead, Sydney Australia
- Resource Type
- Journal article
- Publication Details
- JAMA neurology, Vol.73(6), pp.645-651
- Publisher
- United States
- DOI
- 10.1001/jamaneurol.2016.0171
- PMID
- 27043305
- PMCID
- PMC4916861
- ISSN
- 2168-6149
- eISSN
- 2168-6157
- Grant note
- G0601943 / Medical Research Council U54 NS065712 / NINDS NIH HHS
- Language
- English
- Date published
- 06/01/2016
- Academic Unit
- Neurology; Molecular Physiology and Biophysics; Stead Family Department of Pediatrics; Iowa Neuroscience Institute
- Record Identifier
- 9984020776502771
Metrics
30 Record Views